Ja‐Der Liang

1.1k total citations
37 papers, 625 citations indexed

About

Ja‐Der Liang is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Ja‐Der Liang has authored 37 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 9 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Ja‐Der Liang's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (6 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Ja‐Der Liang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (6 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Ja‐Der Liang collaborates with scholars based in Taiwan, United States and South Korea. Ja‐Der Liang's co-authors include Guan‐Tarn Huang, Pei–Ming Yang, Jin‐Chuan Sheu, Yi‐Ju Tseng, Feipei Lai, Mei–Hsuan Lee, Ling‐Ling Chiou, Chien‐Hung Chen, Jong Yun Won and Wen-Yen Huang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ja‐Der Liang

36 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ja‐Der Liang Taiwan 14 255 177 163 129 93 37 625
Wei Qiang Leow Singapore 13 213 0.8× 248 1.4× 133 0.8× 200 1.6× 95 1.0× 47 717
Chee Leong Cheng Singapore 16 227 0.9× 361 2.0× 230 1.4× 193 1.5× 178 1.9× 36 1.0k
Na Cheng China 9 120 0.5× 126 0.7× 146 0.9× 143 1.1× 77 0.8× 29 576
Kiat‐Hon Lim Singapore 12 92 0.4× 143 0.8× 111 0.7× 264 2.0× 112 1.2× 16 614
Feng Han China 18 218 0.9× 189 1.1× 234 1.4× 240 1.9× 151 1.6× 59 969
Sören Weidemann Germany 12 182 0.7× 191 1.1× 117 0.7× 88 0.7× 87 0.9× 37 501
Alessandro Gambella Italy 15 169 0.7× 84 0.5× 100 0.6× 122 0.9× 281 3.0× 50 645
Chih‐Wei Yu Taiwan 17 261 1.0× 192 1.1× 102 0.6× 115 0.9× 268 2.9× 41 936
Huijie Jiang China 13 132 0.5× 73 0.4× 204 1.3× 83 0.6× 65 0.7× 60 636

Countries citing papers authored by Ja‐Der Liang

Since Specialization
Citations

This map shows the geographic impact of Ja‐Der Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ja‐Der Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ja‐Der Liang more than expected).

Fields of papers citing papers by Ja‐Der Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ja‐Der Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ja‐Der Liang. The network helps show where Ja‐Der Liang may publish in the future.

Co-authorship network of co-authors of Ja‐Der Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Ja‐Der Liang. A scholar is included among the top collaborators of Ja‐Der Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ja‐Der Liang. Ja‐Der Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Ja‐Der, Po‐Chin Liang, Chia‐Tung Shun, et al.. (2025). In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 12. 1191–1204.
2.
3.
Weng, Meng‐Tzu, et al.. (2023). In situ vaccination followed by intramuscular poly-ICLC injections for the treatment of hepatocellular carcinoma in mouse models. Pharmacological Research. 188. 106646–106646. 5 indexed citations
4.
Heo, Jeong, Ja‐Der Liang, Hyun Young Woo, et al.. (2023). Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial. Molecular Therapy. 31(7). 2077–2088. 22 indexed citations
5.
Liang, Ja‐Der, et al.. (2022). 小鼠非酒精性脂肪性肝炎早期YAP活性变化特征及其与胆管反应的时空关系. PubMed Central. 1 indexed citations
6.
Lv, Ke, Hongyan Zhai, Yuxin Jiang, et al.. (2021). Prospective assessment of diagnostic efficacy and safety of SonazoidTM and SonoVue® ultrasound contrast agents in patients with focal liver lesions. Abdominal Radiology. 46(10). 4647–4659. 27 indexed citations
7.
Kim, Nalee, Jason Chia‐Hsien Cheng, Inkyung Jung, et al.. (2020). Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma. Journal of Hepatology. 73(1). 121–129. 115 indexed citations
8.
Kudo, Masatoshi, Yasunori Minami, Yi‐Hong Chou, et al.. (2020). The AFSUMB consensus statements and recommendations for the clinical practice of contrast-enhanced ultrasound using sonazoid. Journal of Medical Ultrasound. 28(2). 59–59. 29 indexed citations
9.
Chou, Yi‐Hong, Ja‐Der Liang, Shen-Yung Wang, et al.. (2019). Safety of perfluorobutane (Sonazoid) in characterizing focal liver lesions. SHILAP Revista de lepidopterología. 27(2). 81–81. 16 indexed citations
10.
Wang, Yan, Xieer Liang, Hui Wang, et al.. (2017). Improved performance of quantitative collagen parameters versus standard histology in longitudinal assessment of nonadvanced liver fibrosis for chronic hepatitis B. Journal of Viral Hepatitis. 25(5). 598–607. 5 indexed citations
11.
Shun, Shiow‐Ching, et al.. (2016). The Role of Age in Change in Unmet Supportive Care Needs in Hepatocellular Carcinoma Patients During Transition From Hospital to Home. Cancer Nursing. 40(3). 245–254. 5 indexed citations
12.
Huang, Yu‐Wen, Ja‐Der Liang, Ling‐Ling Chiou, et al.. (2015). Brain Isoform Glycogen Phosphorylase as a Novel Hepatic Progenitor Cell Marker. PLoS ONE. 10(3). e0122528–e0122528. 2 indexed citations
13.
Liang, Ja‐Der, et al.. (2014). Recurrence predictive models for patients with hepatocellular carcinoma after radiofrequency ablation using support vector machines with feature selection methods. Computer Methods and Programs in Biomedicine. 117(3). 425–434. 38 indexed citations
14.
Tseng, Yi‐Ju, Yu‐Fang Chung, Ya-Lin Wu, et al.. (2013). Information Extraction for Tracking Liver Cancer Patients' Statuses: From Mixture of Clinical Narrative Report Types. Telemedicine Journal and e-Health. 19(9). 704–710. 23 indexed citations
15.
Chung, Yu‐Fang, Yi‐Ju Tseng, Ja‐Der Liang, et al.. (2013). A Web-Based Data-Querying Tool Based on Ontology-Driven Methodology and Flowchart-Based Model. JMIR Medical Informatics. 1(1). e2–e2. 2 indexed citations
16.
Liang, Ja‐Der, Chien‐Hung Chen, Shih–Jer Hsu, et al.. (2011). Hepatocellular carcinoma with duodenal invasion and metastasis. Journal of Gastroenterology and Hepatology. 27(4). 677–683. 6 indexed citations
17.
18.
Su, Pei‐Fen, Te‐Chang Lee, Pei‐Ju Lin, et al.. (2007). Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma. International Journal of Cancer. 121(6). 1257–1264. 72 indexed citations
19.
Lee, Mei–Hsuan, James L. Sherley, Jeremy J.W. Chen, et al.. (2005). EMP-1 is a junctional protein in a liver stem cell line and in the liver. Biochemical and Biophysical Research Communications. 334(4). 996–1003. 24 indexed citations
20.
Liang, Ja‐Der, Chi‐Tai Fang, Yee‐Chun Chen, Shan‐Chwen Chang, & Kwen‐Tay Luh. (2001). Candida albicans spinal epidural abscess secondary to prosthetic valve endocarditis. Diagnostic Microbiology and Infectious Disease. 40(3). 121–123. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei Qiang Leow Breakdown of academic impact, for papers by Chee Leong Cheng Breakdown of academic impact, for papers by Na Cheng Breakdown of academic impact, for papers by Kiat‐Hon Lim Breakdown of academic impact, for papers by Feng Han Breakdown of academic impact, for papers by Sören Weidemann Breakdown of academic impact, for papers by Alessandro Gambella Breakdown of academic impact, for papers by Chih‐Wei Yu Breakdown of academic impact, for papers by Huijie Jiang
Rankless by CCL
2026